Split hand/foot malformation associated with 20p12.1 deletion: A case report.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 22 10 2019
accepted: 02 11 2019
pubmed: 8 11 2019
medline: 1 1 2021
entrez: 8 11 2019
Statut: ppublish

Résumé

Split hand/foot malformation (SHFM) or ectrodactyly is a rare congenital disorder affecting limb development characterized by clinical and genetic heterogeneity. SHFM is usually inherited as an autosomal dominant trait with incomplete penetrance. Isolated and syndromic forms are described. The extent of associated malformations is highly variable and multiple syndromes with clinical and genetic overlap have been described. We report here a 28 year-old man presenting with SHFM, sparse hair and widespread freckles. Array-CGH identified a 450 kb de novo 20p12.1 microdeletion encompassing three exons (exon 6 to 8) of MACROD2. Although MACROD2 mutations have not been associated with limb malformation until now, it is located next to KIF16B, which is involved in fibroblast growth factor receptor (FGFR) signaling. Additionally, the deletion encompassed a histone modification H3K27ac mark, known as a provider of quantitative readout of promoter and enhancer activity during human limb development. Altogether, these findings suggest that the 20p12.1 CNV is causative of SHFM in the present case through disturbance of regulatory elements functioning.

Identifiants

pubmed: 31698100
pii: S1769-7212(19)30693-7
doi: 10.1016/j.ejmg.2019.103805
pii:
doi:

Substances chimiques

KIF16B protein, human 0
MACROD2 protein, human 0
Hydrolases EC 3.-
Kinesins EC 3.6.4.4
DNA Repair Enzymes EC 6.5.1.-

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103805

Informations de copyright

Copyright © 2019. Published by Elsevier Masson SAS.

Auteurs

Lyse Ruaud (L)

Centre de Génétique Humaine, CHU Besançon, Université de Franche -Comté, Besançon, France; Université de Paris, NeuroDiderot, INSERM, F-75019 Paris, France; Service de génétique clinique, APHP, Hôpital Robert Debré, F-75019 Paris, France.

Ricarda Flöttmann (R)

Charité - Universitätsmedizin Berlin, Institut für Medizinische Genetik, Germany.

Malte Spielmann (M)

Charité - Universitätsmedizin Berlin, Institut für Medizinische Genetik, Germany.

Fabienne Escande (F)

Laboratoire de Biochimie et Biologie Moléculaire, CHU Lille, F-59000 Lille, France; EA7364 RADEME, Univiversité de Lille, F-59000 Lille, France.

Lionel Van Maldergem (L)

Centre de Génétique Humaine, CHU Besançon, Université de Franche -Comté, Besançon, France.

Stefan Mundlos (S)

Charité - Universitätsmedizin Berlin, Institut für Medizinische Genetik, Germany.

Juliette Piard (J)

Centre de Génétique Humaine, CHU Besançon, Université de Franche -Comté, Besançon, France. Electronic address: jpiard@chu-besancon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH